Variant report

Variant	rs763030
Chromosome Location	chr3:50528092-50528093
allele	C/G
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type
1	chr3:50526587..50528932-chr3:50530037..50531864,2	MCF-7	breast:
2	chr3:50526765..50528739-chr3:50533687..50536379,2	MCF-7	breast:
3	chr3:50525621..50528608-chr3:50539997..50541654,2	MCF-7	breast:

Variant related genes	Relation type
ENSG00000007402	Chromatin interaction

Extended variants
information (count: 82 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:70)

rs_ID	r²[population]
rs1107265	0.89[CEU][hapmap]
rs12490042	0.84[CEU][hapmap]
rs12494849	1.00[CEU][hapmap];0.90[CHB][hapmap];0.91[JPT][hapmap];0.91[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs13087550	0.84[CEU][hapmap]
rs1467913	1.00[CEU][hapmap];0.90[CHB][hapmap];0.91[JPT][hapmap];0.88[AMR][1000 genomes];0.95[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs1467914	1.00[CEU][hapmap];0.95[CHB][hapmap];0.91[JPT][hapmap];0.90[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs2236953	0.83[CEU][hapmap]
rs2236954	0.94[CEU][hapmap]
rs2236955	0.89[CEU][hapmap]
rs2236956	0.84[CEU][hapmap]
rs2236957	0.89[CEU][hapmap]
rs2236958	0.87[CEU][hapmap]
rs2236959	0.89[CEU][hapmap]
rs2236961	0.83[CEU][hapmap]
rs2236963	0.83[CEU][hapmap]
rs2236964	0.89[CEU][hapmap]
rs2236965	0.89[CEU][hapmap]
rs2236967	0.83[CEU][hapmap]
rs2236968	0.83[CEU][hapmap]
rs2236969	0.89[YRI][hapmap]
rs2236971	0.80[CEU][hapmap]
rs2236973	0.89[CEU][hapmap]
rs2236975	0.83[CEU][hapmap]
rs2236979	0.89[CEU][hapmap]
rs2236984	0.89[CEU][hapmap]
rs2236987	0.89[CEU][hapmap]
rs2236988	0.83[CEU][hapmap]
rs2282752	0.94[CEU][hapmap]
rs2282753	0.89[CEU][hapmap]
rs2282754	0.89[CEU][hapmap]
rs2282756	0.83[CEU][hapmap]
rs2282758	0.84[CEU][hapmap]
rs2298955	0.89[CEU][hapmap]
rs34704833	0.85[EUR][1000 genomes]
rs34762184	0.94[CEU][hapmap];0.85[EUR][1000 genomes]
rs34860383	0.85[EUR][1000 genomes]
rs35053615	0.87[EUR][1000 genomes]
rs35198275	0.87[EUR][1000 genomes]
rs35335661	0.87[EUR][1000 genomes]
rs35684775	0.87[EUR][1000 genomes]
rs35829757	0.87[EUR][1000 genomes]
rs35908181	0.85[EUR][1000 genomes]
rs35986136	0.94[CEU][hapmap];0.87[EUR][1000 genomes]
rs36046126	0.82[EUR][1000 genomes]
rs36059704	0.87[EUR][1000 genomes]
rs4688719	0.88[CEU][hapmap]
rs57361338	0.85[EUR][1000 genomes]
rs58432784	0.87[EUR][1000 genomes]
rs61018691	0.85[EUR][1000 genomes]
rs61423002	0.85[EUR][1000 genomes]
rs6786523	1.00[CEU][hapmap];0.90[CHB][hapmap];0.91[JPT][hapmap];0.92[AMR][1000 genomes];0.96[EUR][1000 genomes];0.94[ASN][1000 genomes]
rs6787890	0.83[CEU][hapmap]
rs6792502	1.00[CEU][hapmap];0.84[AMR][1000 genomes];1.00[EUR][1000 genomes];0.99[ASN][1000 genomes]
rs6807916	0.94[CEU][hapmap];0.85[EUR][1000 genomes]
rs71326934	0.87[EUR][1000 genomes]
rs734767	0.89[CEU][hapmap]
rs73835511	0.87[EUR][1000 genomes]
rs73835517	0.85[EUR][1000 genomes]
rs743756	0.89[CEU][hapmap]
rs743757	0.89[CEU][hapmap]
rs743856	0.81[AMR][1000 genomes];0.81[EUR][1000 genomes]
rs743857	0.89[CEU][hapmap]
rs7613931	0.87[EUR][1000 genomes]
rs762895	0.83[CEU][hapmap]
rs762897	0.88[CEU][hapmap]
rs762898	0.83[CEU][hapmap]
rs916217	0.83[CEU][hapmap]
rs929047	0.83[CEU][hapmap]
rs9835537	0.89[CEU][hapmap]
rs9867588	1.00[CEU][hapmap];0.95[CHB][hapmap];0.91[JPT][hapmap];0.94[AMR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:12 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv523662	chr3:50144951-50584999	Flanking Bivalent TSS/Enh Weak transcription Genic enhancers Bivalent Enhancer Strong transcription Transcr. at gene 5' and 3' Flanking Active TSS Enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	101 gene(s)	inside rSNPs	diseases
2	esv1821728	chr3:50156142-50657253	Strong transcription Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Genic enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	109 gene(s)	inside rSNPs	diseases
3	nsv470561	chr3:50158774-50584999	Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	99 gene(s)	inside rSNPs	diseases
4	nsv876770	chr3:50158774-50609624	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS ZNF genes & repeats Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	103 gene(s)	inside rSNPs	diseases
5	nsv1001993	chr3:50187646-50640808	Weak transcription Enhancers Flanking Active TSS Active TSS Genic enhancers Bivalent/Poised TSS Bivalent Enhancer Strong transcription Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	104 gene(s)	inside rSNPs	diseases
6	esv3584502	chr3:50368278-50659741	Strong transcription Bivalent/Poised TSS Enhancers Weak transcription Flanking Active TSS Active TSS Genic enhancers Transcr. at gene 5' and 3' Bivalent Enhancer Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	55 gene(s)	inside rSNPs	diseases
7	nsv432419	chr3:50388396-50637496	Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Bivalent Enhancer Active TSS Genic enhancers Strong transcription Bivalent/Poised TSS ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	32 gene(s)	inside rSNPs	diseases
8	nsv1013225	chr3:50440826-50700448	Flanking Active TSS Enhancers Genic enhancers Weak transcription Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
9	nsv536566	chr3:50440826-50700448	Genic enhancers Weak transcription Flanking Active TSS Enhancers Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	35 gene(s)	inside rSNPs	diseases
10	nsv984540	chr3:50473691-50669310	Enhancers Weak transcription Genic enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Active TSS Bivalent/Poised TSS Strong transcription Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	28 gene(s)	inside rSNPs	diseases
11	nsv1012501	chr3:50483037-50679591	Bivalent Enhancer Flanking Active TSS Enhancers Weak transcription Genic enhancers Active TSS Transcr. at gene 5' and 3' Bivalent/Poised TSS Strong transcription Flanking Bivalent TSS/Enh ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases
12	nsv536567	chr3:50483037-50679591	Bivalent Enhancer Strong transcription Flanking Active TSS Weak transcription Enhancers Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers Transcr. at gene 5' and 3' ZNF genes & repeats	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	27 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:30 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:50492600-50528400	Weak transcription	Gastric	stomach
2	chr3:50520400-50530400	Weak transcription	Primary T helper naive cells from peripheral blood	blood
3	chr3:50520800-50528400	Weak transcription	Spleen	Spleen
4	chr3:50522000-50533600	Weak transcription	Lung	lung
5	chr3:50525000-50528200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
6	chr3:50527200-50529200	Enhancers	Fetal Muscle Leg	muscle
7	chr3:50527200-50529400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
8	chr3:50527400-50529200	Enhancers	Primary hematopoietic stem cells short term culture	blood
9	chr3:50527400-50529400	Bivalent Enhancer	Fetal Muscle Trunk	muscle
10	chr3:50527400-50529800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr3:50527600-50529400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr3:50527600-50529600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
13	chr3:50527600-50530000	Enhancers	Right Ventricle	heart
14	chr3:50527800-50528200	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
15	chr3:50527800-50528200	Enhancers	Fetal Kidney	kidney
16	chr3:50527800-50528400	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
17	chr3:50527800-50528800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr3:50527800-50529400	Enhancers	Primary hematopoietic stem cells	blood
19	chr3:50527800-50529600	Enhancers	Fetal Thymus	thymus
20	chr3:50527800-50529800	Enhancers	Left Ventricle	heart
21	chr3:50528000-50528400	Enhancers	Breast Myoepithelial Primary Cells	Breast
22	chr3:50528000-50528600	Enhancers	ES-I3 Cell Line	embryonic stem cell
23	chr3:50528000-50528600	Enhancers	HUES64 Cell Line	embryonic stem cell
24	chr3:50528000-50529000	Enhancers	H1 Cell Line	embryonic stem cell
25	chr3:50528000-50529000	Enhancers	HUES6 Cell Line	embryonic stem cell
26	chr3:50528000-50529000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr3:50528000-50529000	Enhancers	Right Atrium	heart
28	chr3:50528000-50529000	Enhancers	Skeletal Muscle Male	skeletal muscle
29	chr3:50528000-50529000	Enhancers	Thymus	Thymus
30	chr3:50528000-50532800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links